Home

Východní Timor Přemoci kyselý markers for identification of resectable pancreatic cancer patients manželka šance deka

Cureus | Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective  Review of Molecular Advances | Article
Cureus | Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances | Article

Identification of a novel serum biomarker for pancreatic cancer,  C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis  using tandem mass tags | British Journal of Cancer
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags | British Journal of Cancer

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic  cancer - eBioMedicine
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer - eBioMedicine

CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports

Biosensors | Free Full-Text | An Exosomal miRNA Biomarker for the Detection  of Pancreatic Ductal Adenocarcinoma
Biosensors | Free Full-Text | An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma

Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic  cancer: a meta-analysis of aggregate and individual participant data -  eClinicalMedicine
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine

Frontiers | Detection of Circulating Tumor Cells in Resectable Pancreatic  Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
Frontiers | Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker

Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic  Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient  Management
Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management

Soluble AXL is a novel blood marker for early detection of pancreatic  ductal adenocarcinoma and differential diagnosis from chronic pancreatitis  - eBioMedicine
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine

Early detection of pancreatic cancer - The Lancet Gastroenterology &  Hepatology
Early detection of pancreatic cancer - The Lancet Gastroenterology & Hepatology

The molecular biology of pancreatic adenocarcinoma: translational  challenges and clinical perspectives | Signal Transduction and Targeted  Therapy
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy

Tumor markers in pancreatic cancer: a European Group on Tumor Markers  (EGTM) status report. | Semantic Scholar
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar

Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada  - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library
Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library

Implementing biological markers as a tool to guide clinical care of patients  with pancreatic cancer - ScienceDirect
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect

Cancers | Free Full-Text | Use of Biomarkers and Imaging for Early Detection  of Pancreatic Cancer
Cancers | Free Full-Text | Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer

Cancers | Free Full-Text | Diagnostic Bioliquid Markers for Pancreatic  Cancer: What We Have vs. What We Need
Cancers | Free Full-Text | Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need

Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews

Circulating tumor DNA as a prognostic indicator in resectable pancreatic  ductal adenocarcinoma: A systematic review and meta-analysis | Scientific  Reports
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports

Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of  Patients With Pancreatic Cancer: A Meta-Analysis - Yong-Ming Kang, Hao  Wang, Ran Li, Gu Pan, 2021
Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis - Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan, 2021

Diagnostics | Free Full-Text | Early Detection of Pancreatic Cancer: Role  of Biomarkers in Pancreatic Fluid Samples
Diagnostics | Free Full-Text | Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples

What Makes a Pancreatic Cancer Resectable? | American Society of Clinical  Oncology Educational Book
What Makes a Pancreatic Cancer Resectable? | American Society of Clinical Oncology Educational Book

Harnessing the Microbiome for Pancreatic Cancer Immunotherapy: Trends in  Cancer
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy: Trends in Cancer

Identification of candidate diagnostic and prognostic biomarkers for  pancreatic carcinoma - eBioMedicine
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine

Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Cancers | Free Full-Text | Circulating Tumor Cells in Pancreatic Cancer:  Current Perspectives
Cancers | Free Full-Text | Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives

Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely  Precursor Detection and Increased Curative-Intent Surgery - Kjetil Søreide,  Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia, 2023
Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery - Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia, 2023